GlassScriptPhysician profile
Stanley J Rogers
NPI 1487698791
$100,728.41
in general payments reported to CMS, 2019-2025
11 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,952 · 2020: $713 · 2021: $9,331 · 2022: $13K · 2023: $10K · 2024: $47K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Travel and Lodging: $7,674 · Food and Beverage: $5,313 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,801.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,070.00 |
| Travel and Lodging | $7,674.24 |
| Food and Beverage | $5,312.62 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $68,707.86 | 2021-2025 | Signia, Ligasure, Biosyn |
| Ethicon INC. | $19,226.03 | 2023-2024 | |
| Intuitive Surgical, INC. | $11,032.12 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $745.97 | 2020-2025 | Phasix Mesh |
| Covidien LP | $439.30 | 2019 | |
| Enterra Medical, INC. | $296.95 | 2024 | |
| Boston Scientific Corporation | $106.19 | 2025 | Overstitch Endoscopic Suturing System |
| Octapharma USA, INC. | $62.81 | 2025 | Fibryga |
| Applied Medical Resources Corporation | $61.60 | 2021 | |
| Ethicon US, LLC | $49.58 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$681,225.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.